Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info: https://youtu.be/811v7RLXP9M
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Thursday, October 8, 2020

Daniel talks TMAU with Dr. Lucy McKay CEO of M4RD

Daniel is one of our leading activists in promoting awareness of TMAU and the concept of Metabolic Malodor.
He uses his youtube channel to chat with people about it.

In his latest video, he talks to Dr Lucy McKay, CEO of the charity MEDICS 4 RARE DISEASES.

About M4RD
Medics4RareDiseases is a registered charity driving an attitude change towards rare diseases amongst medical students and doctors in training.

Lucy McKay is a UK trained doctor and the CEO of Medics4RareDiseases. Lucy’s brother had a rare disease and she grew up around people with rare diseases. She studied Human Genetics at The University of Nottingham and then graduated from medicine at Barts and The London School of Medicine and Dentistry, QMUL, in 2014. Lucy completed her Foundation Training in West Yorkshire before becoming a locum in Paediatrics and then CEO of M4RD.  



get New Posts by EMAIL : Enter your email address :


A EURORDIS and NORD Member Organization

0 comments:

Post a Comment